Familial Hypomagnesemia with Secondary Hypocalcemia Mimicking Neurodegenerative Disorder

Mahesh Kamate1, Neha Singh, Supriya Patil

  • 1Department of Pediatrics, KLE Universitys J N Medical College, Belgaum, Karnataka, India. Correspondence to: Dr Mahesh Kamate, Professor of Pediatrics, KLE Universitys J N Medical College, Belgaum 590 010, Karnataka, India. drmaheshkamate@gmail.com.

Indian Pediatrics
|June 30, 2015
PubMed

Insights

Familial hypomagnesemia, a genetic disorder, can cause severe infant seizures. Prompt diagnosis and oral magnesium supplementation effectively control symptoms, preventing tragic outcomes.

Area of Science:

  • Genetics
  • Pediatric Neurology
  • Metabolic Disorders

Background:

  • Familial hypomagnesemia with secondary hypocalcemia is a rare genetic disorder affecting magnesium metabolism.
  • It typically manifests in infancy with severe, treatment-resistant seizures.
  • This condition can lead to significant neurological complications if not diagnosed and managed promptly.

Purpose of the Study:

  • To report a case of familial hypomagnesemia presenting with medically-refractory seizures and cerebral atrophy.
  • To highlight the importance of early diagnosis and appropriate management in preventing severe outcomes.
  • To emphasize the role of genetic counseling and timely intervention in families with a history of unexplained infant deaths.

Main Methods:

  • Case report of an infant diagnosed with familial hypomagnesemia.
  • Neuroimaging was performed, revealing cerebral atrophy.
  • Treatment involved oral magnesium supplementation.

Main Results:

  • The infant presented with medically-refractory seizures.
  • Cerebral atrophy was observed on neuroimaging.
  • Seizures were successfully controlled with oral magnesium supplementation.

Conclusions:

  • Familial hypomagnesemia should be strongly considered in infants presenting with recurrent or refractory hypocalcemic seizures.
  • Early recognition and treatment with magnesium are crucial for managing this condition.
  • Accurate diagnosis is vital to prevent mortality and neurological sequelae in affected infants and families.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
996
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K